Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference0.9%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check41 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check55 days agoChange DetectedThe page has removed a citation regarding the safety, efficacy, and tolerability of efgartigimod in patients with generalized myasthenia gravis, which was previously included.SummaryDifference0.3%
Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.